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Prostate cancer is the most 
common malignancy found in males
and the second leading cause of 
cancer death in US men. Therefore, 
identification of promising 
chemopreventive agents may have
a significant impact on public health.
G. Lucidum (Linzhi or Reishi), is the most popular 
mushroom used in Traditional Chinese Medicine (TCM) for over 
2000 years for the promotion of vitality and longevity, and is 
hypothesized to have anti-cancer activities1. 
PC-SPES is an herbal mixture previously marketed by 
Botanic Lab (Brea, LA) from 1966 to 2002 and used by patients 
with prostate cancer2. G. Lucidum is one of the eight herbs used
in PC-SPES.  PC-SPES was successfully tested with promising 
results in phase II clinical trials as an effective agent in the
treatment of advanced prostate cancer2,3. However, PC-SPEC 
was withdrawn from the market in 2002 after being found to have 
been supplemented with estrogens, anticoagulants and 
analgescs2,3. Although published research with PC-SPES is 
invalid, further research focusing upon the individual 
components, such as G. Lucidum are of critical importance. The 
water extracts of the sporoderm-broken spores of G. Lucidum
contain bioactive components, such as polysaccharides, that 
maybe responsible for the anti-cancer activity of G.  Lucidum 4.  
We have conducted a series of studies to determine the potential
of this agent for future development as a chemopreventive agent 
or adjunct to prostate cancer therapy.
Materials. The sporoderm-broken spore product of G. Lucidum 
was provided as a kind gift from Chinese  Academy of Science. 
All the antibodies were purchased from Cell Signaling (Beverly, 
MA). The 3-[4,5-2-yl]-2-, 5-diphenyltetrazolium bromide (MTT) 
were obtained from Sigma (St. Louis, MO).
Water extraction. The sporoderm-broken spores of G. 
Lucidum (100g)  were extracted with 2 L of water at 70º C in a 
water bath with agitation for 12 h.  The aqueous fraction 
obtained from centrifugation was lypholized with Labconco
Lyph-Lock 4.5 Freeze Dry System (Corona, CA) and stored at -
20º C. The freeze-dried sporoderm-broken spore water extracts 
(SBSWE) were then dissolved in appropriate medium at 
indicated concentrations for subsequent experiments. 
Cell Proliferation Assay. Cells were plated in 96-well 
microtiter plates at an initial density of 2 x 104 cells per well. 
Cells were treated with SBSWE (0, 1.25, 2.5, 5, and 10 mg/ml) 
and incubated for an additional 24, 48 or 72 h. After incubation, 
cell proliferation was determined by the MTT assay according 
to manufacturer’s instruction (Sigma, MO). 
Cell culture. Human prostate non-cancerous RWPE-1 and 
cancerous PC-3 cells were purchased from ATCC (Rockville, 
MD). Normal human prostate epithelial cells (PrEC) were 
purchased from Clonetics (Walkersville, MD). All cells were 
maintained in appropriate growth medium at 37º C in 5% CO2. 
Immunoblotting. Cells were grown and treated with SBSWE in 
35-mm dishes (75% confluent). After appropriate treatments, 
cell lysates were collected and protein concentrations were 
measured. Approximately 30 µg protein was electrophoresed 
on a 10% SDS-polyacrylamide gel followed by standard 
immunoblotting procedures according to manufacturer’s 
instruction (Cell Signaling, MA).
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ABSTRACT
Ganoderma Lucidum (Linzhi or Reishi), the most popular 
mushroom used in Traditional Chinese Medicine (TCM), has 
been used in Asian countries over thousand years for the 
treatment and prevention of many diseases, including 
cancer. However, the molecular mechanisms responsible for 
the anti-cancer effects of G.Lucidum remain to be 
elucidated. The objective of the current study was to 
determine the effects of the sporoderm-broken spore water 
extracts (SBSWE) of G.Lucidum on cell proliferation, 
apoptosis and the molecular targets in prostate cancer PC-3 
cells. Our data demonstrated that the SBSWE (1.25 mg/ml -
10 mg/ml) significantly inhibited the proliferation of PC-3 
cells in both a time- and dose-dependent manner. SBSWE 
treatment at 10 mg/ml for 72 hr produced maximal inhibitory 
effect on the PC-3 cell growth by 85% compared to the 
control. Western blot revealed that the growth inhibitory 
effects were associated with activation of caspase-9, 
caspase-3, caspase-6, and the cleavage of the poly (ADP-
ribose) polymerase (PARP) in PC-3 cells. In addition, the 
phosphorylation of the extracellular signal-regulated kinase 
(Erk) was significantly inhibited by SBSWE in both a time-
and dose-dependent manner. Phosphorylated Akt was also 
downregulated by SBSWE treatment in PC-3 cells. 
However, the activity of p38 was significantly upregulated by 
SBSWE treatment in these cells. We also determined that 
SBSWE were able to inhibit the growth of the normal human 
prostate epithelial isolate PrEC and the prostate non-
tumorigenic RWPE-1 cells in a dose-dependent manner. 
Taken together, these observations suggest that the 
SBSWE of G.Lucidum contain very potent phytochemicals 
which effectively inhibited the growth of prostate PC-3 cells 
by targeting multiple signaling pathways. METHODS
OBJECTIVE
RESULTS
CONCLUSIONS FUTURE DIRECTIONS
INTRODUCTION
To determine the effect of sporoderm-
broken spore water extracts on cell 
proliferation in prostate cancer and non-
cancer cells. 
To examine the mechanisms by which the 
sporoderm-broken spore water extracts  
regulate the growth of human prostate cells. 
HYPOTHESIS
An aqueous extract of sporoderm-
broken spores of G. Lucidum will 
have anti-proliferative and pro-
apoptotic effects on human prostate 
cancer cells. 
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Figure 1. Dose- and time-dependent inhibition of the growth of prostate 
cancer PC-3 cells by SBSWE. PC-3 cells were treated with SBSWE 
(0 – 10 mg/ml) for 24, 48 and 72 h followed by MTT assay. All experiments
were repeated three times in duplicate. Data represent Mean + SD. A 
p-value of < 0.05 is considered as significant.  
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Figure 2. Dose-dependent inhibition of the growth of prostate non-cancerous 
PWPE-1 and normal PrEC cells by SBSWE. RWPE-1 and PrEC cells were
treated with SBSWE (0 – 10 mg/ml) for 24 h followed by MTT assay. All 
experiments were repeated three times. Data are represented as Mean +
SD. A p-value of < 0.05 is considered as significant.  
Effect on MAPKs and Akt Signaling  
Figure 3. Time-dependent regulation of MAPKs and Akt signaling in
PC-3 cells by SBSWE. PC-3 cells were treated with SBSWE at 
10 mg/ml for indicated time points (0 – 240 min). Cell lysates were
collected and analyzed by immunoblotting for phosphorylated Erk 
(p-Erk), total Erk (t-Erk), phosphorylated Akt (p-Akt), total Akt (t-Akt)
and phosphorylated p38 (p-p38). 
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Figure 4. Dose-dependent regulation of Erk phosphorylation in PC-3 
cells by SBSWE. PC-3 cells were treated with SBSWE (0 – 10 mg/ml) 
for 1 h. Cell lysates were collected and analyzed by immunoblotting for 
phosphorylated Erk (p-Erk) and total Erk (t-Erk). One representative 
blot and its quantification (by Scion Image Software) are given.
Effect on apoptotic Signaling  
Figure 5. Time-dependent regulation of caspase and PARP cleavage in
PC-3 cells by SBSWE. PC-3 cells were treated with SBSWE at 10 mg/ml for 
indicated time points (6 – 48 h). Control 1 (Con 1) was collected at 6 h without 
treatment. Control 2 (Con 2) was collected at 48 h without treatment. Cell lysates 
were collected and analyzed by immunoblotting for full length caspase -3, -6, -9 
and PARP. 
Working Model  
Figure 6. Schematic drawing of the mechanisms by which SBSWE of  
G. Lucidum regulate the growth of prostate cancer PC-3 cells. SBSWE may 
directly activate the apoptosis pathway by activating the death receptor FADD or 
the mitochondrial-mediated signalings. SBSWE may also inhibit cell proliferation 
and survival though the inhibition of MAPK/Erk and Akt pathways.
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In memorium (1962-2006):  Russell D. Klein, Ph.D passed away 
on December 1, 2006 after a year long battle with leukemia at the 
James Cancer Hospital.  He will be greatly missed by his 
colleagues and students as a superb scientist, mentor, and 
gentleman.
Water extracts of the sporoderm-broken spores 
of G. Lucidum inhibite the growth of human 
prostate cancer PC-3 cells in a time- and dose-
dependent manner. 
Water extracts of the sporoderm-broken spores 
of G. Lucidum inhibit growth promoting and 
survival pathways involving MAPKs, Akt, 
caspases, and PARP.  
To further define the effects of SBSWE on 
cellular and molecular pathways involved in 
growth inhibition and activation of apoptotic 
pathways in prostate cancer cells.
To determine the effects of SBSWE on 
prostate tumorigenesis and carcinogenesis in 
vivo. 
To isolate and quantitate the bioactive 
components in SBSWE of G. Lucidum. 
